Murine gammaherpesvirus M2 gene is latency-associated and its protein a target for CD8+ T lymphocytes

Proceedings of the National Academy of Sciences of the United States of America

Volumn 96, Issue 13, 1999, Pages 7508-7513

  Husain, S Mazher ^a   Usherwood, Edward J ^a   Dyson, Heather ^c   Coleclough, Christopher ^a,b   Coppola, Michael A ^a   Woodland, David L ^a,b   Blackman, Marcia A ^a,b   Stewart, James P ^c   Sample, Jeffery T ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MESSENGER RNA; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; HERPES VIRUS; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; T LYMPHOCYTE SUBPOPULATION; TUMOR CELL LINE; VIRUS LATENCY;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; GAMMAHERPESVIRINAE; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRIDAE INFECTIONS; MICE; VIRAL MATRIX PROTEINS; VIRUS LATENCY;

ANIMALIA; HERPES; HERPESVIRIDAE; HUMAN HERPESVIRUS 4; MURINAE; MURINE HEPATITIS VIRUS;

EID: 0033594943     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.96.13.7508     Document Type: Article

References (35)

1. Rickinson, A. B. & Kieff, E. (1996) in Fields Virology, eds. Fields, B. N., Knipe, D. M. & Howley, P. M. (Lippincott, New York), pp. 2397-2446.
2. Ganem, D. (1997) Cell 91, 157-160.
3. Boshoff, C. & Weiss, R. A. (1998) in Advances in Cancer Research, eds. Vande Woude, G. F. & Klein, G. (Academic, London), pp. 57-86.
4. Kieff, E. (1996) in Fields Virology, eds. Fields, B. N., Knipe, D. M. & Howley, P. M. (Lippincott, New York), pp. 2343-2396.
5. Tierney, R. J., Steven, N., Young, L. S. & Rickinson, A. B. (1994) J. Virol. 68, 7374-7385.
6. Thorley-Lawson, D. A., Miyashita, E. M. & Khan, G. (1996) Trends Microbiol. 4, 204-208.
7. Miyashita, E. M., Yang, B., Babcock, G. J. & Thorley-Lawson, D. A. (1997) J. Virol. 71, 4882-4891.
8. Shope, T., Dechairo, D. & Miller, G. (1973) Proc. Natl. Acad. Sci. USA 70, 2487-2491.
9. Moghaddam, A., Rosenzweig, M., Lee-Parritz, D., Annis, B., Johnson, R. P. & Wang, F. (1997) Science 276, 2030-2033.
10. Desrosiers, R. C., Sasseville, V. G., Czajak, S. C., Zhang, X., Mansfield, K. G., Kaur, A., Johnson, R. P., Lackner, A. A. & Jung, J. U. (1997) J. Virol. 71, 9764-9769.
11. Sunil-Chandra, N. P., Efstathiou, S., Arno, J. & Nash, A. A. (1992) J. Gen. Virol. 73, 2347-2356.
12. Sunil-Chandra, N. P., Efstathiou, S. & Nash A. A. (1992) J. Gen. Virol. 73, 3275-3279.
13. Usherwood, E. J., Stewart, J. P., Robertson, K., Allen, D. J. & Nash, A. A. (1996) J. Gen. Virol. 7, 2819-2825.
14. Week, K. E., Barkon, M. L., Yoo, L. I., Speck, S. H. & Virgin, H. W. (1996) J. Virol. 70, 6775-6780.
15. Stewart, J. P., Usherwood, E. J., Ross, A. J., Dyson, H. & Nash, A. A. (1998) J. Exp. Med. 187, 1941-1951.
16. Week, K. E., Kim, S. S., Virgin, H. W. & Speck, S. H. (1999) J. Virol. 73, 3273-3283.
17. Ehtisham, S., Sunil-Chandra, N. P. & Nash, A. A. (1993) J. Virol. 67, 5247-5252.
18. Stewart, J. P., Usherwood, E. J., Dutia, B. M. & Nash, A. A. (1998) in Herpesviruses and Immunity, eds. Medveczky, P. G., Friedman, H. & Bendinelli, M. (Plenum, New York), pp. 149-163.
19. Stevenson, P. G., Belz, G. T., Altman, J. D. & Doherty, P. C. (1999) Eur. J. Immunol. 29, 1059-1067.
20. Virgin, H. W., Latreille, P., Wamsley, P., Hallsworth, K., Week, K. E., Dal Canto, A. J. & Speck, S. H. (1997) J. Virol. 71, 5894-5904.
21. Usherwood, E. J., Stewart, J. P. & Nash, A. A. (1996) J. Virol. 70, 6516-6518.
22. Nonkwelo, C., Ruf, I. K. & Sample, J. (1997) J. Virol. 71, 6887-6897.
23. Efstathiou, S., Ho, Y. M. & Minson, A. C. (1990) J. Gen. Virol. 71, 1355-1364.
24. Bowden, R. J., Simas, J. P., Davis, A. & Efstathiou, S. (1997) J. Gen. Virol. 78, 1675-1687.
25. Geysen, H. M., Meleon, R. H. & Barteling, S. J. (1984) Proc. Natl. Acad. Sci. USA 81, 3992-4002.
26. Murali-Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J., Zajac, A. J., Miller, J. D., Slansky, J. & Ahmed, R. (1998) Immunity 8, 177-187.
27. Stewart, J. P., Janjua, N. J., Sunil-Chandra, N. P., Nash, A. A. & Arrand, J. R. (1994) J. Virol. 68, 6496-6504.
28. Stewart, J. P., Janjua, N. J., Pepper, S. deV., Bennion, G., Mackett, M., Allen, T., Nash, A. A. & Arrand, J. R. (1996) J. Virol. 70, 3528-3535.
29. Pepper, S. deV., Stewart, J. P., Arrand, J. R. & Mackett, M. (1996) Virology 219, 475-479.
30. Mackett, M., Stewart, J. P., Pepper, S. deV., Chee, M., Efstathiou, S., Nash, A. A. & Arrand, J. R. (1997) J. Gen. Virol. 78, 1425-1433.
31. Rammensee, H. G., Friede, T. & Stevanoviic, S. (1995) Immunogenetics 41, 178-228.
32. Cole, G. A., Hogg, T. L., Coppola, M. A. & Woodland, D. L. (1997) J. Immunol. 158, 4301-4309.
33. Virgin, H. W., Presti, R. M., Li, X.-Y., Liu, C. & Speck, S. H. (1999) J. Virol. 73, 2321-2332.
34. Fries, K. L., Sculley, T. B., Webster-Cyriaque, J., Rajadurai, P., Sadler, R. H. & Raab-Traub, N. (1997) J. Virol. 71, 2765-2771.
35. Sample, J., Liebowitz, D. & Kieff, E. (1989) J. Virol. 63, 933-937.